Recently, the "omnigenic" model of the genetic architecture of complex traits proposed two 46 general categories of causal genes, core and peripheral. Core genes are hypothesized to play a 47 direct role in regulating disease; thus, their identification has the potential to reveal critical 48 regulators and novel therapeutic targets. Here, we sought to identify genes with "core-like" 49 characteristics for bone mineral density (BMD), one of the most significant predictors of 50 osteoporotic fracture. This was accomplished by analyzing genome-wide association study 51 (GWAS) data through the lens of a cell-type and timepoint-specific gene co-expression network 52 for mineralizing osteoblasts. We identified a single co-expression network module that was 53 enriched for genes implicated by GWAS and partitioned BMD heritability, correlated with in vitro 54 osteoblast mineralization, and enriched for genes, which when mutated in humans or mice, led 55 to a skeletal phenotype. Further characterization of this module identified four novel genes 56 (B4GALNT3, CADM1, DOCK9, and GPR133) located within BMD GWAS loci with colocalizing 57 expression quantitative trait loci (eQTL) and altered BMD in mouse knockouts, suggesting they 58 are causal genetic drivers of BMD in humans. Our network-based approach identified a "core" 59 module for BMD and provides a resource for expanding our understanding of the genetics of 60 bone mass. 61 62 63 64 65 66 67 68 69 70 3
4 peripheral has the potential to highlight previously undiscovered key regulatory genes for 97 specific trait-related biological processes, which may be more ideal therapeutic targets. 98
There are two main challenges in the identification of core genes. The first is how to 99 precisely define them 12,15-17. In the omnigenic model, a gene is defined as a "core" gene "if and 100 only if the gene product (protein, or RNA for a noncoding gene) has a direct effect-not 101 mediated through regulation of another gene-on cellular and organismal processes leading to 102 a change in the expected value of a particular phenotype" 11,12. This statistical definition is 103 convenient for explaining the omnigenic model, but is difficult to utilize for the identification of 104 core genes in practice. It is also very strict; e.g. is RUNX2, as described above, a core gene for 105 BMD? Instead we propose to use a set of biologically motivated criteria to distinguish genes 106 with core-like properties from those that are likely peripheral by leveraging known pathways and 107 processes that are essential to a disease-associated trait. For example, we would expect the 108 expression of genes with core-like properties operating in pathways of critical importance in the 109 regulation of BMD to be correlated with BMD and their severe perturbation to have a substantial 110 impact on BMD (e.g., monogenic disease genes). 111
The second challenge is designing a strategy to identify genes with core-like properties, 112 since GWAS alone is incapable of determining whether a locus is driven by a core or peripheral 113 gene. One of the primary tenets of the omnigenic model is that peripheral genes account for a 114 substantial component of the heritability of a trait because their effects are amplified by 115 interactions with networks of co-expressed core genes 12. If one expects core genes to be co-116 expressed then integrating the results of GWAS with co-expression networks, which reflect the 117 transcriptional programs associated with the trait of interest, is a logical approach to identify 118 modules of genes with core-like properties. A number of studies have already successfully used 119 co-expression networks to inform GWAS, however this approach has not been used in the 120 context of the omnigenic model 18-22. 121 Here, we combine weighted gene co-expression network analysis (WGCNA) and BMD 122 5 GWAS data to identify genes that are causal genetic drives of BMD with core-like properties. 123
Our approach used a co-expression network for mature, mineralizing osteoblasts which we 124 hypothesized would allow us to identify core genes specific for the process of mineralization. 125 6 The goal of this work was to use a cell-and stage-specific co-expression network to 149 identify genes with core-like properties that are causal for BMD GWAS associations. We chose 150 to focus on generating a co-expression network using transcriptomic data from a single cell-type 151 at a single-time point during differentiation: mature, mineralizing osteoblasts. We hypothesized 152 this would allow us to focus on genes with core-like properties in the context of mineralization, a 153 process critical in the regulation of BMD. We began by using WGCNA to construct a co-154 expression network using transcriptomic profiles generated from mineralizing primary calvarial 155 osteoblasts from 42 strains of Collaborative Cross (CC) mice 23. The CC is a panel of genetically 156 diverse recombinant inbred strains. The resulting network consisted of 65 modules of genes, 157 with an average of 292 genes per module (Figure 1 and Supplemental File 1). Each co-158 expression module was distinguished by its assigned color (e.g., the purple module). 159
To confirm that modules of genes produced by the co-expression analysis represented 160 transcriptional programs reflecting specific biological processes, we assessed whether modules 161 were enriched for genes associated with specific gene ontology (GO) terms 24. Most network 162 modules were enriched for general biological processes, such as the immune response (Padj = 163 6.6 x 10-36) in the blue module, mRNA metabolism (Padj = 7.8 x 10-9) in the darkolivegreen 164 module, and chromatin remodeling (Padj = 1.9 x 10-4) in the grey60 module (Figure 1 and  165 Supplemental File 2). However, as would be expected, there were a subset of modules 166 enriched for genes involved in the activity of osteoblasts. For example, the cyan module was 167 enriched for members of the Wnt signaling pathway (a key regulator of osteoblast activity) (Padj 168 = 2.3 x 10-4), the turquoise module was enriched for genes encoding extracellular matrix 169 proteins (Padj = 3.5 x 10-25) (such as genes encoding for collagens (Padj = 0.4 x 10-10)), and the 170 purple module was enriched for genes involved in skeletal system development (Padj = 2.3 x 10-171 10) and osteoblast differentiation (Padj = 2.0 x 10-6) (Figure 1 and Supplemental File 2). Given 172 that network modules represented distinct biological processes, including those involved in 173 mineralization and osteoblast activity, we were confident it would provide a platform for 7 identifying core genes related to mineralization that potentially underlie BMD GWAS 175 associations. 176 177 Figure 1. Weighted gene co-expression network generated using transcriptomic profiles from 178 mineralizing osteoblasts. The network was composed of 65 modules of co-expressed genes, 179 many of which were enriched for specific biological processes relevant to osteoblasts. 180
181

II. Identification of co-expression modules enriched for genes implicated by GWAS 182
To identify modules of co-expressed genes informative for GWAS, we first determined if 183 any of the 65 modules were enriched for genes that overlapped GWAS associations. Using data 184 from the two largest GWASs performed at the time, one study of Dual Energy X-Absorptiometry 185 (DEXA) derived areal BMD measures at the lumbar spine and femoral neck 8 ("Estrada et al. 186 GWAS"; N=32,961) and one study of ultrasound determined heel estimated BMD (eBMD) 9 187 ("Kemp et al. GWAS", N=142, 487) , we developed a list of 789 human genes (NEstrada = 179, 188 NKemp = 701, (91 shared genes)) intersecting BMD GWAS loci. A total of 723 (92%) of these had 189 mouse homologs in the network (Supplemental File 3 and 4). Of the 65 modules in the 190 network, 13 were enriched for mouse homologs of human genes implicated by BMD GWAS 191 (Fisher's exact test, Padj < 0.05) (Supplemental File 5 and Figure 2A ). Additionally, we 192 8 performed stratified LD score regression by calculating the BMD heritability partitioned by SNPs 193 surrounding genes in each module using the Kemp et al. GWAS 9, 25. We found 16 modules 194 enriched for partitioned BMD heritability, including nine of the 13 enriched for BMD GWAS 195 implicated genes (Figure 2B and Supplemental File 6). 196 197 III. The purple module is enriched for genes with core-like properties 198
Next, we focused on identifying which of the 13 modules identified above were enriched 199 for genes with core-like properties. To accomplish this, we selected modules using biologically 200 motivated criteria which likely reflected the properties of core genes. First, we compared the 13 201 module eigengenes with in vitro mineralization using osteogenic cultures from the same 42 CC 202 strains used in the construction of the co-expression network (Supplemental Figure 1 ). Only 203 one, the purple module, had a pattern of expression that was significantly correlated with 204 mineralization (r = 0.49, Padj = 0.012), suggesting the purple module was enriched for genes 205 with a direct role in mineralization ( Figure 2C and Supplemental Figure 2) . 206
Core genes have been broadly defined as those that directly influence a disease-207 relevant biological processes 11,12. Thus, severe perturbation of a core gene is more likely to 208 result in a significant impact on a phenotype, as in the case of a mouse knockout or human 209 monogenic disease. We identified all gene knockouts that produced a bone phenotype, defined 210 as either a change in BMD, bone mineral content (BMC), abnormal bone morphology, or 211 abnormal bone cell activity, by utilizing mouse knockout phenotype data from several databases 212 [26] [27] [28] [29] (Supplemental File 7) . Of the 13 modules enriched for BMD GWAS genes, two were 213 enriched for genes whose deficiency impacted bone in mice ( Figure 2D) . The purple module 214 was the most significantly enriched (OR=5.4, Padj = 1.6 x 10-34). We also compiled a list of 35 215 known drivers of monogenic bone diseases associated with osteoblast dysfunction, including 216 osteogenesis imperfecta, hyperostosis, and osteosclerosis (Supplemental File 8) [30] [31] [32] [33] [34] 217 the purple module, containing 11 of 35 (31.4%) monogenic disease genes, was the most 218 9 significantly enriched (OR = 21.3, Padj = 6.9 x 10-9) (Figure 2E ). Together, these independent 219 lines of evidence suggested the purple module was enriched for genes with core-like properties. 220 The purple module was enriched for GO categories important for the function of 277 osteoblasts. Consistent with this observation, it contained many genes known to play key roles 278 in osteoblast differentiation and mineralization, including Runx2 13, Sp7 35, Sost 36, 37, Bglap 38, 279 Alpl 39, among many others (Supplemental File 12) . Thus, to further investigate the purple 280 module, we evaluated the expression of its genes with regards to osteoblast differentiation. To 281 do this, we utilized transcriptomic profiles collected from purified osteoblasts at multiple time 282 points across differentiation (GSE54461). Using k-means clustering, we found that the genes 283 within the purple module clearly partitioned into two distinct transcriptional profiles with regards 284 to differentiation (Figure 4A,B) . We have termed these groups the Early Differentiation 285 Submodule (EDS; high expression early and low expression late) (N=192 transcripts; 175 286 unique genes) and the Late Differentiation Submodule (LDS; low expression early and high 287 expression late) (N=423 transcripts; 323 unique genes). 288
We assessed whether there were differences between the EDS and the LDS with regard 289 to network parameters and their enrichment for functional annotations seen in the purple 290 module. We first looked at intramodular connectivity, measured by module membership 291 (correlation between the expression of each gene and the module eigengene). On average, 292 LDS genes had higher module membership scores than EDS genes (P = 3.0 x 10-4) ( Figure  293 4C), suggesting they may play more critical roles in the context of overall module behavior. 294
Additionally, the LDS was more significantly enriched for genes implicated by GWAS (OR = 3.0, 295 Padj = 5.2 x 10-10), osteoblast relevant GO terms (e.g. "ossification" (Padj = 3.24x10-14), skeletal 296 development" (Padj = 9.6 x 10-11), "osteoblast differentiation" (Padj = 1.4 x 10-4), and "biomineral 297 tissue development" (Padj = 4.1x10-6), genes that when knocked-out result in a bone phenotype 298 (OR = 7.3, Padj = 1.1 x 10-33) and monogenic bone disease genes (OR = 33.2, Padj = 8.4 x 10-299 11) ( Figure 4D ). As one would expect based on their higher expression later in differentiation, 300 many of the most well-known regulators of mineralization, such as Phospho1 40, Bglap 41, 301 13 Fam20c 42, Mepe 43, Phex 44, to name a few, were members of the LDS (Supplemental File 302 12). These observations, together with the fact that LDS genes are expressed at high levels 303
during late differentiation, coincident with when the osteoblasts are actively mineralizing, 304 suggest that LDS contains genes with core-like properties specific for the process of with GO terms for bone development, for genes that when knocked out, produce a bone 317 phenotype, and for genes involved in monogenic bone disorders. 318 319 VI. BMD-associated variants in GWAS loci harboring LDS genes overlap active regulatory 320
elements in osteoblasts 321
Based on the fact that the LDS is enriched for genes involved in osteoblast 322 differentiation and that mineralization is fundamental in the regulation of BMD, we anticipate that 323 many of the genes in the LDS are true core genes and causal genetic drivers of BMD. If true, 324 then BMD-associated variants in associations harboring LDS genes should regulate the 325 expression of LDS genes in osteoblasts. To test this, we utilized histone modification data from 326 the Roadmap Epigenome Project 45. In the Morris et al. BMD GWAS, 48 LDS genes overlapped 327 84 associations (7.6% of the 1103 total; a subset of LDS genes overlapped multiple clustered 328 associations). For each of the 84 independently associated lead (i.e., most significant) SNPs, 329
we analyzed histone modifications across the osteoblast genome and observed that they were 330 more likely to overlap regions marked by modifications associated with active regulatory 331 elements such as H3K4me1 (2.8x enrichment, P < 1 x 10-3), H3Kme2 (3.2x enrichment, P < 1 x 332 10-3), H3K4me3 (3.8x enrichment, P < 1 x 10-3), and H3K27ac (2.6x enrichment, P < 1 x 10-3) 333 relative to 1000 sets of random SNPs matched for allele frequency and distance from a 334 transcription start site (Figure 5) . Additionally, we observed depletion of LDS SNPs in 335 heterochromatic regions, marked by H3K9me3 (0.14x depletion, P < 1 x 10-3). 336
To determine if the enrichments were specific to osteoblasts, we calculated the ratio 337 between the LDS BMD set overlap and the mean random set overlap across all 129 Roadmap 338 tissues and cell-types. For all activating marks (H3K27ac, H3K4me1, H3K4me2, H3K4me3) 339 osteoblasts were in the top 10% when tissues were ranked based on the overlap ratio 340 (Supplemental File 13) . The tissues for which the random sets had a higher ratio included cell 341 types within the same lineage as osteoblasts, such as mesenchymal stem cell (MSC) derived 342 chondrocytes and other MSC-derived tissues including adipose and skeletal muscle. These 343 data support the premise that loci harboring LDS genes impact BMD through the regulation of 344 gene expression in osteoblasts, further supporting the causality of LDS genes. 345 346 Together, these data allowed us to directly link BMD associated variants to LDS genes and LDS 362 genes to pathways regulating BMD. We performed a colocalization analysis for each 363 eQTL/BMD association pair for all 48 genes in 48 GTEx tissues and identified 12 LDS genes 364 with colocalizing eQTL (PP4>0.7) (Supplemental File 14 and Figures 6A, B, C, and D) . We 365 also queried each of 12 LDS genes with a colocalizing eQTL and found that BMD had been 366 measured by the IMPC in 5 mutants. Of these, four genes (Cadm1, B4galnt3, Dock9, and 367 Adgrd1) had significantly altered total body BMD (Padj < 0.05) (Supplemental File 15 and 368 Figures 6E, F, G and H) . For Cadm1 and Dock9 the direction of effect inferred from the 369 eQTL/BMD association matched the direction of the effect observed in the mouse knockout; 370 however, for B4galnt3 and Adgrd1 the directions did not match (Supplemental File 15) . 371
Lastly, we evaluated network parameters of Cadm1, B4galnt3, Dock9 and Adgrd1. We 372 observed that Cadm1 and B4galnt3 were ranked in the top 20 based on LDS connectivity 373 (Supplemental File 12). In fact, Cadm1 was the 2nd most highly connected gene. Together, 374 the four genes had, on average, higher module membership than the average LDS gene (0.72 375 vs. 0.52; P = 0.002). In support of the importance of connectivity in the LDS, we observed that 376 more highly connected LDS genes were more likely (P=0.008) to overlap a BMD GWAS locus 377 (Supplemental Figure 3A) and there was a strong positive correlation between connectivity 378 and in vitro mineralization for all LDS genes (r = 0.71, P< 2.2 x 10-16) (Supplemental Figure  379   3B ). These data suggest that connectivity is an important feature of the LDS and a strong proxy 380 for biological importance. Furthermore, these data strongly support CADM1, B4GALNT3, 381 Osteoporosis is an increasingly common disease associated with reduced BMD and 393 negative health outcomes, namely fracture 1. Despite its significant genetic component, we do 394 not fully understand the genes and mechanisms that influence osteoporosis and its 395 determinants, such as BMD. Moreover, current therapeutics for osteoporosis have been 396 associated with rare side effects, leading to decreased compliance 47. Identification of the causal 397 genes with core-like properties that regulate BMD will help us to further understand the etiology 398 of osteoporosis and lead to the development of novel therapeutics. In this study, we identified 399 the LDS, a co-expression submodule enriched for genes with core-like properties influencing 400 BMD, by integrating a cell-and timepoint-specific co-expression network with the results of BMD 401 GWAS. We then used this information to identify four LDS genes that overlapped GWAS loci, 402 had colocalizing eQTL, and altered BMD in knockouts, suggesting they are causal for their 403 respective BMD GWAS association. 404 In this work, we hypothesized that the genes underlying BMD GWAS associations are 405 not created equal with respect to "biological importance" or membership in pathways with direct 406 impacts on bone mass. Substantial prior evidence supports this prediction 48,49and it is one of 407 the primary tenets of the omnigenic model 11,12. Identification of genes whose activity or function 408 is more proximal to BMD is important for a number of reasons. First, the identification of genes 409 with core-like properties has the potential to identify critical new players in pathways known to 410 directly impact bone and to uncover new processes essential to skeletal growth and 411 maintenance. Second, it provides a way to prioritize hundreds of BMD GWAS loci for further 412 investigation. Third, based on their central role in the regulation of BMD, it is logical to use the 413 concept of a core gene as a way to prioritize gene discovery in the context of selecting 414 promising new therapeutic targets for evaluation. 415
The omnigenic model uses a strict statistical definition to define core genes and many 416 19 have debated the utility of this designation11,15-17. Some have argued that focusing on core 417 genes underestimates the complexity of complex traits, attributing biologically nuanced diseases 418 to a small set of genes 13. Others have argued that the focus should not be on thoroughly 419 defining core genes, but instead on identifying the underlying biological pathways and 420 mechanisms 14. In practice, it is likely that the designation of core genes follows a spectrum 421 rather than a discrete classification. If so, then it should be possible to rank genes based on 422 their continuous "core" attributes, which would be analogous to ranking genes based on their 423 proximity to a disease or phenotype. In essence, that is what we have done in the current study 424 with the goal of identifying genes on the end of the "core" attribute distribution for mineralization. 425 Importantly, it is not likely that all genes in the LDS are causal genetic drivers or, if they are 426 causal, it is possible that several will have few core attributes. However, based on our analysis 427 and results, it is likely that many are causal genes that participate in "core" pathways and 428 processes that directly impact mineralization, bone formation, and BMD. 429
As we have previously demonstrated 50,51, there are a number of advantages to using 430 co-expression networks to inform GWAS. First, it allowed us to group genes across the genome 431 based on function and pathway membership and then identify groups of functionally similar 432 genes that had core-like properties. Second, it allowed us to predict the function of potentially 433 casual genetic drivers of BMD. Based on the strong GO enrichments and membership of genes 434 with well-known roles in bone formation and mineralization, it is likely that all LDS genes, 435
including those with no known function, impact mineralization in some manner. The idea of the 436 LDS playing a central role in bone formation was further supported by the strong overlap 437 observed between lead BMD GWAS SNPs for associations containing LDS genes regulatory 438 elements in osteoblasts. Third, it begins to provide a systems-level context for causal genetic 439 drivers. Once genes underlying GWAS loci are identified it is then important to begin to 440 understand their role in complicated cellular networks, defining how a set of genetic variants 441 may converge on multiple genes all involved in a particular process. We can use the LDS to 442 20 begin to identify sets of variants that all work to influence genes which impact mineralization and 443 the hierarchy of relationships between these genes. 444
This work extends our use of co-expression networks to inform GWAS. Previously, we 445 used a network generated using cortical bone expression profiles from the Hybrid Mouse 446 Diversity Panel to identify two "osteoblast" modules (enriched for genes involved in osteoblast 447 differentiation and function) enriched for genes implicated by BMD GWAS. We used these 448 modules to identify 35 genes potentially causal for GWAS loci, including two (MARK3 and 449 SPTBN1) that we experimentally validated their involvement in BMD. Comparing the two 450 modules to the LDS we observed a modest overlap (96 of 323 genes; 29.7%), even though they 451 both demonstrated a strong "osteoblast" enrichment signature. While a number of differences 452 (microarray vs. RNA-seq transcriptomic data, different mouse populations, etc.) confound the 453 interpretation of the seemingly low overlap, it is likely due in large part to our use of osteoblast-454 specific network capturing the transcriptome at peak mineralization instead of the whole bone 455 tissue representing a small number of osteoblasts. 456
We provided strong supporting evidence that four LDS genes (CADM1, B4GALNT3, 457 DOCK9 and GPR133) are novel regulators of BMD and causal for their respective GWAS 458 association. Prior to this study, none of these genes had been directly connected to the 459 regulation of BMD. CADM1 (Cell Adhesion Molecule 1) is a ubiquitously expressed cell 460 adhesion molecule involved in many biological processes, including cancer, spermatogenesis, 461 and neuronal/mast/epithelial cell function52-54 that had been implicated in osteoclast proliferation 462 and activity55 and as an osteoblast-specific marker in the context of osteosarcoma56,57. 463 B4GALNT3 (Beta-1,4-N-Acetyl-Galactosaminyltransferase 3) is a glycosyltransferase that 464 transfers N-acetylgalactosaine (GalNAc) onto glucosyl residues, thus forming N,N-prime-465 diacetyllactoseadiamine (LacdiNAc), which serves as a terminal structure of cell surface N-466 glycans that contributes to cell signaling 51,52. B4GALNT3 is expressed in bone and associated 467 with circulating levels of sclerostin 53-55. DOCK9 (Dedicator of Cytokinesis 9) is a guanine 468 21 nucleotide-exchange factor (GEF) that activates Cdc4258, which has been shown to regulate 469 osteoclast differentiation and ossification 57,58. GPR133 (Adhesion G Protein-Coupled Receptor 470 D1) is a G protein-coupled receptor that participates in cell-cell and cell-matrix interactions 59. 471 Our results demonstrate the utility of the LDS in broadening our understanding of the molecular 472 and genetic basis of BMD. 473
Our study is not without limitations. First, we used gene expression data from the mouse 474 as a discovery platform, however this may limit the translational applications of the work due 475 biological differences and missing homologs between mouse and human. Secondly, this was 476 not a comprehensive study of the genetic effects driving osteoporosis, because we focused 477 exclusively on the contributions of just one cell type, bone-forming osteoblasts. In future work, 478 this approach could also be applied to other bone cell types. For example, one could use in vitro 479 measures of osteoclast activity as a filter to identify groups of genes influencing bone resorption, 480 and ultimately BMD. Finally, the eQTL comparisons made in this study were not derived from 481 expression data in bone tissue, as bone tissue expression was not measured in the GTEx 482 project. While we identified colocalizing eQTL in other tissues, these eQTL may be irrelevant to 483 BMD or the direction of eQTL effects in non-bone tissues may not reflect the direction of effect 484 in osteoblasts. 485
While we identified four novel regulators of bone mineral density, there is still much to be 486 gleaned from the late differentiation submodule. The LDS is a promising resource for two key 487 applications: (1) causal gene discovery and functional follow up and (2) studying the impact of 488 genetic variation on biological networks and complex phenotypes. There are still many genes 489 with no known connection to BMD in the LDS that are likely important to osteoblast biology and 490 mineralization. Additionally, the LDS is not just a list of candidate genes; it also provides insight 491 into the molecular hierarchy driving osteoblast differentiation and mineralization, which can 492 demonstrate how genetic variation impacts biological networks. The network topology of the 493 LDS can also be used to infer the causal relationships between genetic variants and the many 494 22 genes that influence osteoblast activity. Moving forward, the LDS can serve as a platform for the 495 identification of novel determinants of BMD and for furthering our understanding of the nuanced 496 relationship between genetic variation, molecular phenotypes, and complex traits. 497
In summary, we have used an integrative, network-based method to identify core genes 498 for the process of mineralization and BMD. While the definition of a core gene is still open to 499 debate, we found the expected properties of core genes are effective lenses through which to 500 contextualize GWAS associations. Integrating gene co-expression networks, GWAS data, in 501 vitro and in vivo phenotypic data reflecting "core" properties, and eQTL information has led us to 502 a more complete understanding of the biology and genetics of BMD. 503
504
Methods 505 RNA-seq: Neonatal collaborative cross heads were received from the University of North 506
Carolina. At UNC, neonatal (3-5 days) collaborative cross mice were euthanized by CO2, 507 decapitated onto paper towels soaked in 70% ethanol, and placed in cold PBS on ice for 508 overnight shipping. Once received, calvaria were dissected, paying special attention to brain 509 and interparietal bone removal. Isolated calvaria were placed in 24 well plates containing 0.5 mL 510 of digest solution (0.05% trypsin and 1.5 U/ml collagenase P) and incubated on a rocking 511 platform at 37 degrees during six, fifteen-minute digestions in 0.5 mL of digestion solution. 512
Fraction 1 is discarded and fractions 2-6 are collected. Fractions 2-6 are added to an equal 513 volume of cold plating media (89 mL DMEM, 1 mL 100x Pen/Strep solution, and 10 mL Lot 514 tested FBS). The resulting cells are filtered using a 70-100 mm cell strainer to remove clots, 515 centrifuged at 1000 rpm for 5 minutes and re-suspended in 0.5 ml plating media. The resulting 516 cells are plated in a T25 flask. 24 hours later, cells are washed with PBS, treated with trypsin, 517 counted, and plated at a density of 1.5x105 cells per well in a 12-well plate, and allowed to grow 518 to confluence for 48 hours. After 48 hours of growth, cells are switched to differentiation media 519 expression estimates calculated by assigning multi-mapping reads across the genome using 532 and expectation-maximization algorithm to allocate reads that differentiate between genes, then 533 isoforms of a gene, and then alleles. 534 535 WGCNA network construction: Estimated transcript count data was used as the basis for co-536 expression network construction. We removed transcripts with less than an average tpm <= 0.3 537 tpm across all samples, resulting in 29,000 transcripts used to construct the network. We used a 538 variance stabilizing transformation from the DESeq2 package that decouples the variance from 539 the mean 61. Next, we used PEER in order to remove latent confounding batch effects from our 540 data 62. As per PEER recommendations, we estimated PEER factors equal to one quarter of the 541 number of samples (N = 24) and included covariates in the calculation. We carried out the 542 downstream analysis with the residual values from PEER transformation. Finally, we used 543 quantile normalization to match the distribution of each of the samples in the analysis. 544
The resulting expression data was used to construct a signed, weighted gene co-545 expression network using the weighted gene co-expression network analysis (WGCNA) 546 24 package 63. There were no evident outliers from the hierarchical clustering analysis. The 547 pickSoftThreshold() function from the wgcna package was used to determine the power used to 548 calculate the network. The minimum power value that had an R2 >= 0.9 for the scale-free 549 topology model fit was used, and the network was calculated using a power of 9. We then used 550 the blockwiseModules() function to construct a signed network with a merge cut height of 0.15, 551 and a minimum module size of 20 genes. Using WGCNA, we constructed a signed network 552 composed of 65 modules of co-expressed genes, with an average of 292 genes per module. 553 554 Gene Ontology Analysis: For those modules that were enriched for BMD GWAS genes, we 555 conducted gene ontology analysis to identify the functional categories represented by each 556 module. Using the ToppFun tool on the ToppGene site, we identified the significantly enriched 557 categories for GO molecular functions, GO biological processes, GO cellular components, 558 human and mouse phenotypes, and pathways 64. The significance cutoffs reported for these 559 enrichments were Benjamini & Hochberg corrected FDR q-values. 560 561 Creating BMD GWAS list: In order to identify co-expression modules enriched for BMD GWAS 562 genes, we identified all genes overlapping a BMD GWAS locus using the 2012 and 2017 BMD 563 GWAS 8,9. For each BMD locus, a bin was defined by the furthest upstream and downstream 564
SNPs with LD >= 0.7 as calculated from the European populations in the 1000 genomes phase 565 III data identified using the LDLink LDProxy tool 65. Then, using the Genomic Ranges tool, we 566 identified all genes from the GRCh37/hg19 Ensembl gene set overlapping a BMD GWAS bin 567 66,67. If not gene intersected a bin, we identified the nearest upstream and downstream genes 568 from the bin. The Estrada GWAS resulted in 179 genes and the eBMD GWAS resulted in 701 569 genes, resulting in a list of 731 unique genes. We converted the list of human genes to mouse 570 homologs. 571 25 572 BMD GWAS gene enrichment: In order to identify modules of genes enriched for GWAS 573 genes, we used a fisher's exact test to measure the statistical significance of the representation 574 of GWAS genes in each module. We then applied a Bonferroni correction to correct for testing 575 the enrichment of all 65 modules, and applied a significance cutoff of 0.05 to the adjusted p-576 values, resulting in 13 modules of genes enriched for 2012 and 2017 GWAS genes, and 26 577 modules of genes enriched for 2012, 2017, and 2018 GWAS genes. 578 579 LD Score Regression: In order to evaluate the relevance of the BMD GWAS gene enriched 580 modules we calculated the partitioned heritability of the SNPs in the regions surrounding the 581 genes in each module. We used the LD score regression method, which takes gene lists as an 582 input and returns the enrichment of the associated SNP set for heritability for the tested trait. For 583 each set of modules we tested using this method, we corrected the enrichment p-values for 584 multiple testing using a Bonferroni correction, and applied a p-value cutoff of 0.05 to the 585 adjusted p-values. 586
587
In vitro mineralization measurement and correlation: In order to identify the modules of 588 coexpressed genes with patterns of expression correlated with mineralization, we measured in 589 vitro mineralization in osteogenic cells from the calvaria of 42 strains of collaborative cross mice. 590
After 10 days of differentiation and mineral production, cells are washed with PBS and treated 591 with 10% NBF (1 mL per well) and incubated at room temperature for 15 minutes. The NBF is 592 removed and cells are washed with H2O (1mL x 2). Next, wells are stained with alizarin red ( 0.5 593 mLs, 40 mM @ pH 5.6) for 20 minutes on a shake plate at 120 rpm. Alizarin red stain is then 594 removed, and cells are washed 5 times with deionized H2O for 5 minutes on a shake plate at 595 180 rpm. Once rinsed, the mineralized wells are scanned, and .tiff images are retained to 596
